Order:
  1.  36
    Patients’ views on using human embryonic stem cells to treat Parkinson’s disease: an interview study.Mats Hansson, Elena Jiltsova, Jennifer Viberg Johansson, Trinette Van Vliet, Håkan Widner, Dag Nyholm & Jennifer Drevin - 2022 - BMC Medical Ethics 23 (1):1-10.
    BackgroundHuman embryonic stem cells as a source for the development of advanced therapy medicinal products are considered for treatment of Parkinson’s disease. Research has shown promising results and opened an avenue of great importance for patients who currently lack a disease modifying therapy. The use of hESC has given rise to moral concerns and been the focus of often heated debates on the moral status of human embryos. Approval for marketing is still pending.ObjectiveTo Investigate the perspectives and concerns of patients (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  2.  32
    Patients accept therapy using embryonic stem cells for Parkinson’s disease: a discrete choice experiment.Jennifer Viberg Johansson, Mats Hansson, Elena Jiltsova, Trinette van Vliet, Hakan Widner, Dag Nyholm, Jorien Veldwijk, Catharina Groothuis-Oudshoorn, Jennifer Drevin & Karin Schölin Bywall - 2023 - BMC Medical Ethics 24 (1):1-13.
    BackgroundNew disease-modifying ways to treat Parkinson’s disease (PD) may soon become a reality with intracerebral transplantation of cell products produced from human embryonic stem cells (hESCs). The aim of this study was to assess what factors influence preferences of patients with PD regarding stem-cell based therapies to treat PD in the future.MethodsPatients with PD were invited to complete a web-based discrete choice experiment to assess the importance of the following attributes: (i) type of treatment, (ii) aim of treatment, (iii) available (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  3.  22
    Transforming trash to treasure Cultural ambiguity in foetal cell research.Kristofer Hansson, Håkan Widner, Åsa Mäkitalo, Susanne Lundin & Andréa Wiszmeg - 2021 - Philosophy, Ethics, and Humanities in Medicine 16 (1):1-12.
    BackgroundRich in different kind of potent cells, embryos are used in modern regenerative medicine and research. Neurobiologists today are pushing the boundaries for what can be done with embryos existing in the transitory margins of medicine. Therefore, there is a growing need to develop conceptual frameworks for interpreting the transformative cultural, biological and technical processes involving these aborted, donated and marginal embryos. This article is a contribution to this development of frameworks.MethodsThis article examines different emotional, cognitive and discursive strategies used (...)
    No categories
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark